FOURTH LEASE AMENDMENT
Exhibit 10.1
This Lease Amendment made this 17th day of October, 2022 by and between DUKE & DUKE, a Limited Partnership, of 00000 Xxxxx Xxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxxx Xxxxx, XX 00000, as “Landlord” and Ocuphire Pharma,
Inc. of 00000 Xxxxx Xxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxxx Xxxxx, XX 00000, as “Tenant”.
WITNESSETH
WHEREAS, on or about the 31st day of August, 2021, Landlord and Xxxxxx entered into a Lease Agreement with a First Amendment on
October 29, 2019, a Second Amendment on November 17, 2020, and a Third Amendment on September 9, 2022. The Lease together with any and all Amendments and/or riders is herein collectively referred to as, “Lease”. The certain demised premises
consists of 1,623 rentable square feet and being commonly known as Suite 120 at 00000 Xxxxx Xxxxx Xxxxxx, Xxxxxxxxxx Xxxxx, XX 00000; and
WHEREAS, the parties wish to amend this Lease in respect to the demised premises in that Tenant will extend the term of the Lease; and
NOW THEREFORE, in consideration of monies to be paid and covenants and conditions to be performed, IT IS HEREBY AGREED AS FOLLOWS:
1. That the rent for the Suite known as Suite 120 will be as follows;
01/01/2023 — 12/31/2023 $22.00 per rentable square foot
2. That the expiration date of Tenant’s Lease shall be December 31, 2023.
3. Tenant Share: 2.13%
4. Base Tax: $1.39
5. Miscellaneous: The Lease remains in full force and effect and has not been modified or extended except as specifically set in this Fourth Amendment. To the extent of any conflict between this Amendment and
the Lease, the provisions of this Amendment shall control.
TENANT:
|
LANDLORD:
|
||
DUKE & DUKE,
|
|||
a Limited Partnership
|
|||
/s/ Xxxx Xxxxx
|
/s/ Xxxxxx Xxxx
|
Name:
|
Xxxx Xxxxx
|
Name:
|
Xxxxxx Xxxx
|
Its:
|
CEO
|
Its:
|
Xxxxxx Xxxx Gen Ptnr
|
Date:
|
10/18/2022
|
Date:
|
10/18/2022
|